Risk of variant Creutzfeldt-Jakob disease in a simulated cohort of Canadian blood donors.

vCJD poses minimal risks to the Canadian blood supply. Current vCJD deferral criteria may, therefore, be lifted with virtually no impact on safety, while significantly expanding the donor base.